Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor

Inhibition of the myostatin signaling pathway is emerging as a promising therapeutic means to treat muscle wasting and degenerative disorders. Activin type IIB receptor (ActRIIB) is the putative myostatin receptor, and a soluble activin receptor (ActRIIB-Fc) has been demonstrated to potently inhibit...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rahimov, Fedik, King, Oliver D., Warsing, Leigh C., Powell, Rachel E., Emerson, Charles P., Kunkel, Louis M., Wagner, Kathryn R.
Формат: Artigo
Язык:Inglês
Опубликовано: American Physiological Society 2011
Предметы:
Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3092338/
https://ncbi.nlm.nih.gov/pubmed/21266502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/physiolgenomics.00223.2010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы